CBD is dominating worldwide attention, and while companies big and small are looking to commercialise on the opportunity, regulatory bodies have put the brakes on until full understanding and accompanying laws have been established which has delayed companies in accelerating CBD products to market.

An understanding of the regulatory landscape is essential for companies looking to launch CBD products in the dietary supplements and functional foods sectors.

Charlotte Bastiaanse, associate editor at Vitafoods Insights, and Elba Manzanilla Zapata, senior legal analyst at CBD-Intel, investigate regulation as it stands, the implications of current and future status, finer authorisation procedures, and the key considerations for businesses in the CBD space.